Alzheimer Disease News

• Flavonoids Dietary 'Powerhouses' for Cognitive Decline Prevention A high intake of dietary flavonoids, particularly flavones and anthocyanins, may help maintain cognitive function as individuals age, new research suggests.
  Medscape Medical News, August 09, 2021
• Long COVID Symptoms Rare but Real in Some Kids School-aged children with SARS-CoV-2 infection had mild symptoms and typically recovered in 6 days, a large UK study of smartphone data reassuringly reports.
  Medscape Medical News, August 06, 2021
• Cut Aducanumab Cost, Speed Confirmatory Research, ICER Says The manufacturer of the controversial Alzheimer's drug aducanumab needs to cut its prohibitive cost and speed the pace of research to determine whether the medication actually keeps the disease at bay, ICER says.
  Medscape Medical News, August 05, 2021
• Can Older Adults Walk Their Way Out of Dementia? Low to moderate levels of physical activity in later life mitigate the increased risk for dementia that is commonly associated with aging, new research suggests.
  Medscape Medical News, August 05, 2021
• AAIC 2021 Pandemic Amplifies Urgent Need for Long-term Care Reform The crushing pandemic represents an "inflection point" for needed changes in health care policies related to long-term care, experts say.
  Medscape Medical News, August 05, 2021
• AAIC 2021 Alzheimer's Disease: What's in the Research Pipeline? In the wake of approval of the first anti-amyloid agent, investors and researchers are injecting new energy into exploring multiple strategies to prevent dementia.
  Medscape Medical News, August 05, 2021
• US Science Labs Getting Towering New Equipment The machines are so tall, scientists climb to reach the top to conduct experiments that experts say will advance health research and drug development.
  WebMD Health News, August 05, 2021
• FDA's Accelerated Drug Approval Process Under Investigation A federal watchdog group has announced it will conduct a broad assessment of how regulators approved certain medications, including aducanumab, the controversial drug for Alzheimer's disease.
  Medscape Medical News, August 05, 2021
• AAIC 2021 Repurposed Cancer Drug Shows Promise in Alzheimer's The addition of the antitumor medication masitinib to standard of care significantly slowed cognitive deterioration and improved overall functioning for patients with mild to moderate Alzheimer's disease.
  Medscape Medical News, August 05, 2021
• AAIC 2021 Biogen, Eisai Report Design of Real-World Study of Alzheimer's Treatment Biogen and partner Eisai on Thursday revealed the design of an upcoming study of their controversial Alzheimer's treatment, Aduhelm.
  Reuters Health Information, July 30, 2021
• AAIC 2021 Low-Dose Aspirin Linked to Lower Dementia Risk in Some Two cohorts suggest long-term use of low-dose aspirin may be beneficial ― but primarily in those with cardiovascular risk.
  Medscape Medical News, August 03, 2021
• Modest Calorie Cut Plus Exercise May Improve Vascular Health When it comes to dieting in older patients who are also exercising, more intense calorie restriction is not necessarily better for heart health, new research suggests.
  Medscape Medical News, August 02, 2021
• AAIC 2021 COVID-19 Tied to Acceleration of Alzheimer's Pathology Researchers found higher levels of neurofilament light and other markers of brain injury in COVID patients with neurologic symptoms compared to COVID patients without neurologic symptoms.
  Medscape Medical News, July 30, 2021
• AAIC 2021 Inflammatory Diet Linked to Increased All-Cause Dementia Risk A proinflammatory diet is linked to increased risk for development of all-cause dementia -- but not Alzheimer's disease, new research suggests.
  Medscape Medical News, July 30, 2021
• AAIC 2021 International Push for Recognition of Unique FTD Variant There is an international push by researchers across the globe to have what they believe is a unique variant of frontotemporal dementia recognized.
  Medscape Medical News, July 30, 2021
• AAIC 2021 Blood Biomarkers for Alzheimer's 'Promising' but Nuanced Although several blood tests could be 'powerful' for identifying Alzheimer's disease, results may be affected by other clinical factors, experts say.
  Medscape Medical News, July 30, 2021
• AAIC 2021 'Alarming' Data on Early Cognitive Decline in Transgender Adults Middle-aged transgender adults are nearly twice as likely as cisgender peers to report subjective cognitive decline affecting daily life -- and at an earlier age.
  Medscape Medical News, July 29, 2021
• AAIC 2021 Learning to Salsa Boosts Seniors' Brain Health Learning and practicing Latin dances may lead to improvements in working memory, mobility, and walking speed in older adults, a new randomized controlled trial suggests.
  Medscape Medical News, July 29, 2021
• Biogen Withdrew Aduhelm Paper After JAMA Asked for Edits: Axios Biogen withdrew its paper that analyzed results from the clinical trials of its controversial Alzheimer's drug, Aduhelm, Axios reported on Tuesday, citing two sources familiar with the matter.
  Reuters Health Information, July 28, 2021
• FDA Leaders, Advisory Panel Go Head-to-Head Over Aducanumab FDA leaders and members of the advisory panel that recommended against approval of the controversial Alzheimer's drug aducanumab have gone head-to-head in two perspectives published today in the New England Journal of Medicine.
  Medscape Medical News, July 28, 2021